Author

Michael Franti

Boehringer Ingelheim (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adriana Papadimitropoulou· 1 shared Anthony GavalasiD· 1 shared Chrysanthi Charalampous· 1 shared Diana Reinhardt· 1 shared Gareth R. WillisiD· 1 shared Ioannis SerafimidisiD· 1 shared Johanna SonntagiD· 1 shared Jonas DoerriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Adriana Papadimitropoulou

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacological targeting of SOS1-RAS interaction triggers pancreatic β-cell proliferation and sustainably reverses diabetic hyperglycemia

Adriana Papadimitropoulou, Chrysanthi Charalampous, Paraskevi Kogionou, Diana Reinhardt, Johanna Sonntag, Anthony Gavalas, Marco H. Hofmann, Patrik Erlmann, Michael Franti, Jonas Doerr, Thomas Klein, Gareth R. Willis, Ioannis Serafimidis

This study shows that the SOS1-RAS inhibitor BI-3406 promotes β-cell proliferation and reverses diabetic hyperglycemia in mice.

bioRxiv · Jun 3, 2025 · PreprintCell Biology